nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone decanoate—AR—breast cancer	0.144	0.544	CbGaD
Nandrolone decanoate—CYP19A1—breast cancer	0.121	0.456	CbGaD
Nandrolone decanoate—CYP19A1—Exemestane—breast cancer	0.0791	0.226	CbGbCtD
Nandrolone decanoate—AR—Fluoxymesterone—breast cancer	0.0783	0.223	CbGbCtD
Nandrolone decanoate—CYP19A1—Letrozole—breast cancer	0.0673	0.192	CbGbCtD
Nandrolone decanoate—CYP19A1—Anastrozole—breast cancer	0.06	0.171	CbGbCtD
Nandrolone decanoate—Testosterone—Exemestane—breast cancer	0.0536	0.236	CrCrCtD
Nandrolone decanoate—Norethindrone—Fluoxymesterone—breast cancer	0.0508	0.224	CrCrCtD
Nandrolone decanoate—Progesterone—Fluoxymesterone—breast cancer	0.0428	0.188	CrCrCtD
Nandrolone decanoate—Testosterone Propionate—Fluoxymesterone—breast cancer	0.0428	0.188	CrCrCtD
Nandrolone decanoate—Testosterone—Fluoxymesterone—breast cancer	0.0371	0.164	CrCrCtD
Nandrolone decanoate—CYP19A1—Raloxifene—breast cancer	0.0303	0.0865	CbGbCtD
Nandrolone decanoate—CYP19A1—Tamoxifen—breast cancer	0.02	0.0571	CbGbCtD
Nandrolone decanoate—CYP19A1—Paclitaxel—breast cancer	0.0156	0.0445	CbGbCtD
Nandrolone decanoate—CYP19A1—corpus luteum—breast cancer	0.00634	0.274	CbGeAlD
Nandrolone decanoate—MAOB—nipple—breast cancer	0.000764	0.033	CbGeAlD
Nandrolone decanoate—AR—nipple—breast cancer	0.000719	0.0311	CbGeAlD
Nandrolone decanoate—MAOA—nipple—breast cancer	0.000652	0.0282	CbGeAlD
Nandrolone decanoate—MAOB—embryo—breast cancer	0.000631	0.0273	CbGeAlD
Nandrolone decanoate—Priapism—Tamoxifen—breast cancer	0.000628	0.0081	CcSEcCtD
Nandrolone decanoate—Dysphonia—Exemestane—breast cancer	0.000606	0.00782	CcSEcCtD
Nandrolone decanoate—Dysphonia—Ixabepilone—breast cancer	0.000572	0.00738	CcSEcCtD
Nandrolone decanoate—MAOA—embryo—breast cancer	0.000538	0.0233	CbGeAlD
Nandrolone decanoate—Local reaction—Melphalan—breast cancer	0.000536	0.00692	CcSEcCtD
Nandrolone decanoate—Oligospermia—Methotrexate—breast cancer	0.000509	0.00656	CcSEcCtD
Nandrolone decanoate—Hirsutism—Goserelin—breast cancer	0.000498	0.00643	CcSEcCtD
Nandrolone decanoate—CYP19A1—endometrium—breast cancer	0.00049	0.0212	CbGeAlD
Nandrolone decanoate—AR—epithelium—breast cancer	0.000484	0.0209	CbGeAlD
Nandrolone decanoate—Oligospermia—Epirubicin—breast cancer	0.000476	0.00614	CcSEcCtD
Nandrolone decanoate—Local reaction—Vinorelbine—breast cancer	0.000469	0.00605	CcSEcCtD
Nandrolone decanoate—MAOB—endometrium—breast cancer	0.000461	0.0199	CbGeAlD
Nandrolone decanoate—AR—skin of body—breast cancer	0.00046	0.0199	CbGeAlD
Nandrolone decanoate—CYP19A1—uterus—breast cancer	0.000452	0.0195	CbGeAlD
Nandrolone decanoate—CYP19A1—adipose tissue—breast cancer	0.000442	0.0191	CbGeAlD
Nandrolone decanoate—Oligospermia—Doxorubicin—breast cancer	0.000441	0.00568	CcSEcCtD
Nandrolone decanoate—AR—endometrium—breast cancer	0.000434	0.0188	CbGeAlD
Nandrolone decanoate—MAOB—uterus—breast cancer	0.000425	0.0184	CbGeAlD
Nandrolone decanoate—Seborrhoeic dermatitis—Goserelin—breast cancer	0.000425	0.00548	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Tamoxifen—breast cancer	0.000421	0.00543	CcSEcCtD
Nandrolone decanoate—MAOB—pituitary gland—breast cancer	0.000418	0.018	CbGeAlD
Nandrolone decanoate—MAOB—adipose tissue—breast cancer	0.000416	0.018	CbGeAlD
Nandrolone decanoate—CYP19A1—female reproductive system—breast cancer	0.000406	0.0176	CbGeAlD
Nandrolone decanoate—Hyperlipidaemia—Goserelin—breast cancer	0.000402	0.00519	CcSEcCtD
Nandrolone decanoate—AR—uterus—breast cancer	0.0004	0.0173	CbGeAlD
Nandrolone decanoate—Hoarseness—Paclitaxel—breast cancer	0.000397	0.00512	CcSEcCtD
Nandrolone decanoate—CYP19A1—adrenal gland—breast cancer	0.000396	0.0171	CbGeAlD
Nandrolone decanoate—Azoospermia—Methotrexate—breast cancer	0.000396	0.00511	CcSEcCtD
Nandrolone decanoate—MAOA—endometrium—breast cancer	0.000394	0.017	CbGeAlD
Nandrolone decanoate—AR—pituitary gland—breast cancer	0.000393	0.017	CbGeAlD
Nandrolone decanoate—AR—adipose tissue—breast cancer	0.000391	0.0169	CbGeAlD
Nandrolone decanoate—Amenorrhoea—Chlorambucil—breast cancer	0.000388	0.005	CcSEcCtD
Nandrolone decanoate—Local reaction—Mitoxantrone—breast cancer	0.000387	0.00499	CcSEcCtD
Nandrolone decanoate—MAOB—female reproductive system—breast cancer	0.000382	0.0165	CbGeAlD
Nandrolone decanoate—MAOB—adrenal gland—breast cancer	0.000373	0.0161	CbGeAlD
Nandrolone decanoate—Azoospermia—Epirubicin—breast cancer	0.00037	0.00478	CcSEcCtD
Nandrolone decanoate—Local reaction—Fluorouracil—breast cancer	0.00037	0.00478	CcSEcCtD
Nandrolone decanoate—CYP19A1—female gonad—breast cancer	0.00037	0.016	CbGeAlD
Nandrolone decanoate—MAOA—uterus—breast cancer	0.000363	0.0157	CbGeAlD
Nandrolone decanoate—AR—female reproductive system—breast cancer	0.00036	0.0155	CbGeAlD
Nandrolone decanoate—MAOA—pituitary gland—breast cancer	0.000356	0.0154	CbGeAlD
Nandrolone decanoate—MAOA—adipose tissue—breast cancer	0.000355	0.0153	CbGeAlD
Nandrolone decanoate—AR—adrenal gland—breast cancer	0.000351	0.0152	CbGeAlD
Nandrolone decanoate—Hepatic function abnormal—Idarubicin—breast cancer	0.000349	0.00451	CcSEcCtD
Nandrolone decanoate—MAOB—female gonad—breast cancer	0.000348	0.015	CbGeAlD
Nandrolone decanoate—Amenorrhoea—Tamoxifen—breast cancer	0.000345	0.00445	CcSEcCtD
Nandrolone decanoate—Acne—Goserelin—breast cancer	0.000344	0.00444	CcSEcCtD
Nandrolone decanoate—CYP19A1—endocrine gland—breast cancer	0.000344	0.0149	CbGeAlD
Nandrolone decanoate—Azoospermia—Doxorubicin—breast cancer	0.000343	0.00442	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Melphalan—breast cancer	0.000338	0.00436	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Goserelin—breast cancer	0.00033	0.00425	CcSEcCtD
Nandrolone decanoate—AR—female gonad—breast cancer	0.000327	0.0141	CbGeAlD
Nandrolone decanoate—MAOA—female reproductive system—breast cancer	0.000326	0.0141	CbGeAlD
Nandrolone decanoate—Hoarseness—Capecitabine—breast cancer	0.000326	0.0042	CcSEcCtD
Nandrolone decanoate—MAOB—endocrine gland—breast cancer	0.000323	0.014	CbGeAlD
Nandrolone decanoate—MAOA—adrenal gland—breast cancer	0.000318	0.0138	CbGeAlD
Nandrolone decanoate—Jaundice—Toremifene—breast cancer	0.000309	0.00399	CcSEcCtD
Nandrolone decanoate—Irritability—Letrozole—breast cancer	0.000307	0.00396	CcSEcCtD
Nandrolone decanoate—AR—endocrine gland—breast cancer	0.000304	0.0132	CbGeAlD
Nandrolone decanoate—MAOA—female gonad—breast cancer	0.000297	0.0128	CbGeAlD
Nandrolone decanoate—Fluid retention—Tamoxifen—breast cancer	0.000288	0.00372	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Lapatinib—breast cancer	0.000283	0.00365	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Thiotepa—breast cancer	0.000282	0.00364	CcSEcCtD
Nandrolone decanoate—MAOA—endocrine gland—breast cancer	0.000276	0.0119	CbGeAlD
Nandrolone decanoate—Gynaecomastia—Goserelin—breast cancer	0.000259	0.00334	CcSEcCtD
Nandrolone decanoate—Jaundice—Ixabepilone—breast cancer	0.000257	0.00331	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Toremifene—breast cancer	0.000257	0.00331	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Tamoxifen—breast cancer	0.000252	0.00325	CcSEcCtD
Nandrolone decanoate—Furunculosis—Methotrexate—breast cancer	0.000251	0.00324	CcSEcCtD
Nandrolone decanoate—Hirsutism—Capecitabine—breast cancer	0.000246	0.00318	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Mitoxantrone—breast cancer	0.000244	0.00314	CcSEcCtD
Nandrolone decanoate—Jaundice—Anastrozole—breast cancer	0.000242	0.00312	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Goserelin—breast cancer	0.000241	0.0031	CcSEcCtD
Nandrolone decanoate—CYP19A1—lymph node—breast cancer	0.000238	0.0103	CbGeAlD
Nandrolone decanoate—Fluid retention—Thiotepa—breast cancer	0.000235	0.00304	CcSEcCtD
Nandrolone decanoate—Furunculosis—Epirubicin—breast cancer	0.000235	0.00303	CcSEcCtD
Nandrolone decanoate—Libido decreased—Goserelin—breast cancer	0.000227	0.00293	CcSEcCtD
Nandrolone decanoate—MAOB—lymph node—breast cancer	0.000224	0.00966	CbGeAlD
Nandrolone decanoate—Furuncle—Methotrexate—breast cancer	0.000217	0.0028	CcSEcCtD
Nandrolone decanoate—Furunculosis—Doxorubicin—breast cancer	0.000217	0.0028	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Ixabepilone—breast cancer	0.000213	0.00275	CcSEcCtD
Nandrolone decanoate—Dysphonia—Paclitaxel—breast cancer	0.000212	0.00274	CcSEcCtD
Nandrolone decanoate—AR—lymph node—breast cancer	0.00021	0.00909	CbGeAlD
Nandrolone decanoate—Disturbance in sexual arousal—Goserelin—breast cancer	0.000209	0.00269	CcSEcCtD
Nandrolone decanoate—Furuncle—Epirubicin—breast cancer	0.000203	0.00262	CcSEcCtD
Nandrolone decanoate—Oedema—Toremifene—breast cancer	0.000202	0.00261	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Letrozole—breast cancer	0.000201	0.00259	CcSEcCtD
Nandrolone decanoate—Fluid retention—Gemcitabine—breast cancer	0.000198	0.00255	CcSEcCtD
Nandrolone decanoate—MAOA—lymph node—breast cancer	0.000191	0.00825	CbGeAlD
Nandrolone decanoate—Ethynodiol—PGR—breast cancer	0.000188	0.0597	CrCbGaD
Nandrolone decanoate—Hypertension—Exemestane—breast cancer	0.000188	0.00243	CcSEcCtD
Nandrolone decanoate—Furuncle—Doxorubicin—breast cancer	0.000188	0.00243	CcSEcCtD
Nandrolone decanoate—Nausea—Fluoxymesterone—breast cancer	0.000186	0.00241	CcSEcCtD
Nandrolone decanoate—Jaundice—Chlorambucil—breast cancer	0.000186	0.0024	CcSEcCtD
Nandrolone decanoate—Local reaction—Epirubicin—breast cancer	0.00018	0.00233	CcSEcCtD
Nandrolone decanoate—Oedema—Exemestane—breast cancer	0.000178	0.0023	CcSEcCtD
Nandrolone decanoate—Norelgestromin—PGR—breast cancer	0.000178	0.0564	CrCbGaD
Nandrolone decanoate—Erectile dysfunction—Tamoxifen—breast cancer	0.000175	0.00226	CcSEcCtD
Nandrolone decanoate—Dysphonia—Capecitabine—breast cancer	0.000174	0.00225	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Gemcitabine—breast cancer	0.000173	0.00223	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Docetaxel—breast cancer	0.000168	0.00217	CcSEcCtD
Nandrolone decanoate—Oedema—Ixabepilone—breast cancer	0.000168	0.00217	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Goserelin—breast cancer	0.000167	0.00216	CcSEcCtD
Nandrolone decanoate—Hypertension—Anastrozole—breast cancer	0.000167	0.00216	CcSEcCtD
Nandrolone decanoate—Hypertension—Letrozole—breast cancer	0.000167	0.00216	CcSEcCtD
Nandrolone decanoate—Local reaction—Doxorubicin—breast cancer	0.000167	0.00215	CcSEcCtD
Nandrolone decanoate—Fluid retention—Paclitaxel—breast cancer	0.000166	0.00214	CcSEcCtD
Nandrolone decanoate—Urticaria—Fulvestrant—breast cancer	0.000163	0.0021	CcSEcCtD
Nandrolone decanoate—Jaundice—Melphalan—breast cancer	0.000162	0.00209	CcSEcCtD
Nandrolone decanoate—Norgestimate—PGR—breast cancer	0.00016	0.0508	CrCbGaD
Nandrolone decanoate—Nandrolone phenpropionate—AR—breast cancer	0.000159	0.0505	CrCbGaD
Nandrolone decanoate—Oedema—Letrozole—breast cancer	0.000158	0.00204	CcSEcCtD
Nandrolone decanoate—Oedema—Anastrozole—breast cancer	0.000158	0.00204	CcSEcCtD
Nandrolone decanoate—Jaundice—Goserelin—breast cancer	0.000158	0.00204	CcSEcCtD
Nandrolone decanoate—Pruritus—Lapatinib—breast cancer	0.000158	0.00203	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Epirubicin—breast cancer	0.000146	0.00189	CcSEcCtD
Nandrolone decanoate—Pruritus—Fulvestrant—breast cancer	0.000145	0.00187	CcSEcCtD
Nandrolone decanoate—Pruritus—Toremifene—breast cancer	0.000143	0.00185	CcSEcCtD
Nandrolone decanoate—Irritability—Fluorouracil—breast cancer	0.000142	0.00183	CcSEcCtD
Nandrolone decanoate—Urticaria—Exemestane—breast cancer	0.000141	0.00182	CcSEcCtD
Nandrolone decanoate—Rash—Lapatinib—breast cancer	0.00014	0.00181	CcSEcCtD
Nandrolone decanoate—Fluid retention—Docetaxel—breast cancer	0.00014	0.00181	CcSEcCtD
Nandrolone decanoate—Dermatitis—Lapatinib—breast cancer	0.00014	0.00181	CcSEcCtD
Nandrolone decanoate—Etonogestrel—PGR—breast cancer	0.000139	0.0439	CrCbGaD
Nandrolone decanoate—Hyperlipidaemia—Epirubicin—breast cancer	0.000138	0.00179	CcSEcCtD
Nandrolone decanoate—Fluid retention—Capecitabine—breast cancer	0.000136	0.00175	CcSEcCtD
Nandrolone decanoate—Testosterone Propionate—CYP17A1—breast cancer	0.000136	0.0431	CrCbGaD
Nandrolone decanoate—Seborrhoeic dermatitis—Doxorubicin—breast cancer	0.000135	0.00175	CcSEcCtD
Nandrolone decanoate—Jaundice—Thiotepa—breast cancer	0.000135	0.00174	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Melphalan—breast cancer	0.000134	0.00173	CcSEcCtD
Nandrolone decanoate—Nandrolone phenpropionate—CYP19A1—breast cancer	0.000133	0.0423	CrCbGaD
Nandrolone decanoate—Nausea—Lapatinib—breast cancer	0.000132	0.00171	CcSEcCtD
Nandrolone decanoate—Etonogestrel—SHBG—breast cancer	0.00013	0.0411	CrCbGaD
Nandrolone decanoate—Rash—Fulvestrant—breast cancer	0.000129	0.00167	CcSEcCtD
Nandrolone decanoate—Dermatitis—Fulvestrant—breast cancer	0.000129	0.00167	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Doxorubicin—breast cancer	0.000128	0.00165	CcSEcCtD
Nandrolone decanoate—Rash—Toremifene—breast cancer	0.000128	0.00165	CcSEcCtD
Nandrolone decanoate—Dermatitis—Toremifene—breast cancer	0.000127	0.00164	CcSEcCtD
Nandrolone decanoate—Pruritus—Exemestane—breast cancer	0.000126	0.00162	CcSEcCtD
Nandrolone decanoate—Urticaria—Anastrozole—breast cancer	0.000126	0.00162	CcSEcCtD
Nandrolone decanoate—Urticaria—Letrozole—breast cancer	0.000126	0.00162	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Mitoxantrone—breast cancer	0.000124	0.0016	CcSEcCtD
Nandrolone decanoate—Nausea—Fulvestrant—breast cancer	0.000122	0.00157	CcSEcCtD
Nandrolone decanoate—Dysphonia—Epirubicin—breast cancer	0.000121	0.00156	CcSEcCtD
Nandrolone decanoate—Nausea—Toremifene—breast cancer	0.00012	0.00155	CcSEcCtD
Nandrolone decanoate—Urticaria—Idarubicin—breast cancer	0.000119	0.00154	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Capecitabine—breast cancer	0.000119	0.00153	CcSEcCtD
Nandrolone decanoate—Ethynodiol—ESR1—breast cancer	0.000119	0.0377	CrCbGaD
Nandrolone decanoate—Pruritus—Ixabepilone—breast cancer	0.000119	0.00153	CcSEcCtD
Nandrolone decanoate—Hypertension—Vinblastine—breast cancer	0.000118	0.00152	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Vinorelbine—breast cancer	0.000117	0.00152	CcSEcCtD
Nandrolone decanoate—Jaundice—Mitoxantrone—breast cancer	0.000117	0.00151	CcSEcCtD
Nandrolone decanoate—Jaundice—Irinotecan—breast cancer	0.000117	0.00151	CcSEcCtD
Nandrolone decanoate—Hypertension—Tamoxifen—breast cancer	0.000114	0.00148	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Epirubicin—breast cancer	0.000114	0.00147	CcSEcCtD
Nandrolone decanoate—Rash—Exemestane—breast cancer	0.000112	0.00145	CcSEcCtD
Nandrolone decanoate—Dysphonia—Doxorubicin—breast cancer	0.000112	0.00145	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Thiotepa—breast cancer	0.000112	0.00145	CcSEcCtD
Nandrolone decanoate—Libido decreased—Capecitabine—breast cancer	0.000112	0.00145	CcSEcCtD
Nandrolone decanoate—Dermatitis—Exemestane—breast cancer	0.000112	0.00145	CcSEcCtD
Nandrolone decanoate—Pruritus—Letrozole—breast cancer	0.000112	0.00144	CcSEcCtD
Nandrolone decanoate—Pruritus—Anastrozole—breast cancer	0.000112	0.00144	CcSEcCtD
Nandrolone decanoate—Testosterone Propionate—COMT—breast cancer	0.000111	0.0351	CrCbGaD
Nandrolone decanoate—Hypertension—Goserelin—breast cancer	0.000109	0.00141	CcSEcCtD
Nandrolone decanoate—Estradiol valerate/Dienogest—CYP3A4—breast cancer	0.000109	0.0346	CrCbGaD
Nandrolone decanoate—Oedema—Tamoxifen—breast cancer	0.000108	0.0014	CcSEcCtD
Nandrolone decanoate—Oedema—Melphalan—breast cancer	0.000106	0.00137	CcSEcCtD
Nandrolone decanoate—Rash—Ixabepilone—breast cancer	0.000106	0.00137	CcSEcCtD
Nandrolone decanoate—Dermatitis—Ixabepilone—breast cancer	0.000106	0.00136	CcSEcCtD
Nandrolone decanoate—Nausea—Exemestane—breast cancer	0.000106	0.00136	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Doxorubicin—breast cancer	0.000105	0.00136	CcSEcCtD
Nandrolone decanoate—Oedema—Goserelin—breast cancer	0.000103	0.00133	CcSEcCtD
Nandrolone decanoate—Disturbance in sexual arousal—Capecitabine—breast cancer	0.000103	0.00133	CcSEcCtD
Nandrolone decanoate—Norgestimate—ESR1—breast cancer	0.000101	0.0321	CrCbGaD
Nandrolone decanoate—Nausea—Ixabepilone—breast cancer	9.98e-05	0.00129	CcSEcCtD
Nandrolone decanoate—Rash—Letrozole—breast cancer	9.97e-05	0.00129	CcSEcCtD
Nandrolone decanoate—Rash—Anastrozole—breast cancer	9.97e-05	0.00129	CcSEcCtD
Nandrolone decanoate—Dermatitis—Letrozole—breast cancer	9.96e-05	0.00129	CcSEcCtD
Nandrolone decanoate—Dermatitis—Anastrozole—breast cancer	9.96e-05	0.00129	CcSEcCtD
Nandrolone decanoate—Irritability—Capecitabine—breast cancer	9.92e-05	0.00128	CcSEcCtD
Nandrolone decanoate—Levonorgestrel—PGR—breast cancer	9.81e-05	0.0311	CrCbGaD
Nandrolone decanoate—Hypertension—Vinorelbine—breast cancer	9.79e-05	0.00126	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Irinotecan—breast cancer	9.69e-05	0.00125	CcSEcCtD
Nandrolone decanoate—Urticaria—Chlorambucil—breast cancer	9.66e-05	0.00125	CcSEcCtD
Nandrolone decanoate—Gynaecomastia—Methotrexate—breast cancer	9.54e-05	0.00123	CcSEcCtD
Nandrolone decanoate—Fluid retention—Epirubicin—breast cancer	9.47e-05	0.00122	CcSEcCtD
Nandrolone decanoate—Rash—Raloxifene—breast cancer	9.46e-05	0.00122	CcSEcCtD
Nandrolone decanoate—Rash—Idarubicin—breast cancer	9.46e-05	0.00122	CcSEcCtD
Nandrolone decanoate—Dermatitis—Raloxifene—breast cancer	9.45e-05	0.00122	CcSEcCtD
Nandrolone decanoate—Dermatitis—Idarubicin—breast cancer	9.45e-05	0.00122	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Gemcitabine—breast cancer	9.43e-05	0.00122	CcSEcCtD
Nandrolone decanoate—Nausea—Anastrozole—breast cancer	9.39e-05	0.00121	CcSEcCtD
Nandrolone decanoate—Nausea—Letrozole—breast cancer	9.39e-05	0.00121	CcSEcCtD
Nandrolone decanoate—Hypertension—Thiotepa—breast cancer	9.35e-05	0.00121	CcSEcCtD
Nandrolone decanoate—Levonorgestrel—SHBG—breast cancer	9.16e-05	0.0291	CrCbGaD
Nandrolone decanoate—Nausea—Idarubicin—breast cancer	8.92e-05	0.00115	CcSEcCtD
Nandrolone decanoate—Nausea—Raloxifene—breast cancer	8.92e-05	0.00115	CcSEcCtD
Nandrolone decanoate—Fluid retention—Doxorubicin—breast cancer	8.76e-05	0.00113	CcSEcCtD
Nandrolone decanoate—Etonogestrel—ESR1—breast cancer	8.75e-05	0.0277	CrCbGaD
Nandrolone decanoate—Pruritus—Chlorambucil—breast cancer	8.6e-05	0.00111	CcSEcCtD
Nandrolone decanoate—Urticaria—Tamoxifen—breast cancer	8.6e-05	0.00111	CcSEcCtD
Nandrolone decanoate—Urticaria—Melphalan—breast cancer	8.42e-05	0.00109	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Epirubicin—breast cancer	8.29e-05	0.00107	CcSEcCtD
Nandrolone decanoate—Testosterone Propionate—AR—breast cancer	8.26e-05	0.0262	CrCbGaD
Nandrolone decanoate—Urticaria—Goserelin—breast cancer	8.21e-05	0.00106	CcSEcCtD
Nandrolone decanoate—Hypertension—Irinotecan—breast cancer	8.08e-05	0.00104	CcSEcCtD
Nandrolone decanoate—Hypertension—Mitoxantrone—breast cancer	8.08e-05	0.00104	CcSEcCtD
Nandrolone decanoate—Jaundice—Docetaxel—breast cancer	8.07e-05	0.00104	CcSEcCtD
Nandrolone decanoate—Levonorgestrel—AR—breast cancer	8.04e-05	0.0255	CrCbGaD
Nandrolone decanoate—Norethindrone—PGR—breast cancer	7.95e-05	0.0252	CrCbGaD
Nandrolone decanoate—Mediastinal disorder—Paclitaxel—breast cancer	7.9e-05	0.00102	CcSEcCtD
Nandrolone decanoate—Hypertension—Gemcitabine—breast cancer	7.87e-05	0.00102	CcSEcCtD
Nandrolone decanoate—Jaundice—Capecitabine—breast cancer	7.81e-05	0.00101	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Doxorubicin—breast cancer	7.67e-05	0.000989	CcSEcCtD
Nandrolone decanoate—Pruritus—Tamoxifen—breast cancer	7.66e-05	0.000988	CcSEcCtD
Nandrolone decanoate—Oedema—Mitoxantrone—breast cancer	7.63e-05	0.000985	CcSEcCtD
Nandrolone decanoate—Oedema—Irinotecan—breast cancer	7.63e-05	0.000985	CcSEcCtD
Nandrolone decanoate—Pruritus—Melphalan—breast cancer	7.5e-05	0.000967	CcSEcCtD
Nandrolone decanoate—Oedema—Gemcitabine—breast cancer	7.44e-05	0.00096	CcSEcCtD
Nandrolone decanoate—Norethindrone—SHBG—breast cancer	7.43e-05	0.0235	CrCbGaD
Nandrolone decanoate—Irritability—Methotrexate—breast cancer	7.39e-05	0.000953	CcSEcCtD
Nandrolone decanoate—Urticaria—Vinorelbine—breast cancer	7.35e-05	0.000949	CcSEcCtD
Nandrolone decanoate—Pruritus—Goserelin—breast cancer	7.31e-05	0.000943	CcSEcCtD
Nandrolone decanoate—Oedema—Fluorouracil—breast cancer	7.31e-05	0.000943	CcSEcCtD
Nandrolone decanoate—Nausea—Chlorambucil—breast cancer	7.22e-05	0.000932	CcSEcCtD
Nandrolone decanoate—Urticaria—Thiotepa—breast cancer	7.02e-05	0.000906	CcSEcCtD
Nandrolone decanoate—Rash—Tamoxifen—breast cancer	6.82e-05	0.00088	CcSEcCtD
Nandrolone decanoate—Dermatitis—Tamoxifen—breast cancer	6.82e-05	0.00088	CcSEcCtD
Nandrolone decanoate—Levonorgestrel—CYP19A1—breast cancer	6.73e-05	0.0213	CrCbGaD
Nandrolone decanoate—Mediastinal disorder—Docetaxel—breast cancer	6.7e-05	0.000864	CcSEcCtD
Nandrolone decanoate—Rash—Melphalan—breast cancer	6.68e-05	0.000862	CcSEcCtD
Nandrolone decanoate—Dermatitis—Melphalan—breast cancer	6.67e-05	0.000861	CcSEcCtD
Nandrolone decanoate—Nausea—Vinblastine—breast cancer	6.62e-05	0.000854	CcSEcCtD
Nandrolone decanoate—Hypertension—Paclitaxel—breast cancer	6.59e-05	0.00085	CcSEcCtD
Nandrolone decanoate—Pruritus—Vinorelbine—breast cancer	6.55e-05	0.000845	CcSEcCtD
Nandrolone decanoate—Rash—Goserelin—breast cancer	6.52e-05	0.000841	CcSEcCtD
Nandrolone decanoate—Dermatitis—Goserelin—breast cancer	6.51e-05	0.00084	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Capecitabine—breast cancer	6.48e-05	0.000836	CcSEcCtD
Nandrolone decanoate—Nausea—Tamoxifen—breast cancer	6.43e-05	0.000829	CcSEcCtD
Nandrolone decanoate—Nausea—Melphalan—breast cancer	6.29e-05	0.000812	CcSEcCtD
Nandrolone decanoate—Pruritus—Thiotepa—breast cancer	6.25e-05	0.000807	CcSEcCtD
Nandrolone decanoate—Progesterone—CYP17A1—breast cancer	6.24e-05	0.0198	CrCbGaD
Nandrolone decanoate—Oedema—Paclitaxel—breast cancer	6.23e-05	0.000803	CcSEcCtD
Nandrolone decanoate—Levonorgestrel—ESR1—breast cancer	6.19e-05	0.0196	CrCbGaD
Nandrolone decanoate—Erectile dysfunction—Methotrexate—breast cancer	6.16e-05	0.000795	CcSEcCtD
Nandrolone decanoate—Nausea—Goserelin—breast cancer	6.14e-05	0.000792	CcSEcCtD
Nandrolone decanoate—Urticaria—Mitoxantrone—breast cancer	6.07e-05	0.000783	CcSEcCtD
Nandrolone decanoate—Rash—Vinorelbine—breast cancer	5.84e-05	0.000753	CcSEcCtD
Nandrolone decanoate—Dermatitis—Vinorelbine—breast cancer	5.83e-05	0.000752	CcSEcCtD
Nandrolone decanoate—Urticaria—Fluorouracil—breast cancer	5.81e-05	0.000749	CcSEcCtD
Nandrolone decanoate—Progesterone—ABCC1—breast cancer	5.66e-05	0.0179	CrCbGaD
Nandrolone decanoate—Hypertension—Docetaxel—breast cancer	5.58e-05	0.00072	CcSEcCtD
Nandrolone decanoate—Rash—Thiotepa—breast cancer	5.57e-05	0.000719	CcSEcCtD
Nandrolone decanoate—Dermatitis—Thiotepa—breast cancer	5.57e-05	0.000719	CcSEcCtD
Nandrolone decanoate—Nausea—Vinorelbine—breast cancer	5.5e-05	0.000709	CcSEcCtD
Nandrolone decanoate—Jaundice—Epirubicin—breast cancer	5.44e-05	0.000702	CcSEcCtD
Nandrolone decanoate—Hypertension—Capecitabine—breast cancer	5.41e-05	0.000697	CcSEcCtD
Nandrolone decanoate—Oedema—Docetaxel—breast cancer	5.28e-05	0.000681	CcSEcCtD
Nandrolone decanoate—Pruritus—Gemcitabine—breast cancer	5.26e-05	0.000679	CcSEcCtD
Nandrolone decanoate—Nausea—Thiotepa—breast cancer	5.25e-05	0.000678	CcSEcCtD
Nandrolone decanoate—Pruritus—Fluorouracil—breast cancer	5.17e-05	0.000667	CcSEcCtD
Nandrolone decanoate—Oedema—Capecitabine—breast cancer	5.11e-05	0.000659	CcSEcCtD
Nandrolone decanoate—Jaundice—Doxorubicin—breast cancer	5.03e-05	0.000649	CcSEcCtD
Nandrolone decanoate—Urticaria—Paclitaxel—breast cancer	4.95e-05	0.000638	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Methotrexate—breast cancer	4.83e-05	0.000623	CcSEcCtD
Nandrolone decanoate—Rash—Mitoxantrone—breast cancer	4.81e-05	0.000621	CcSEcCtD
Nandrolone decanoate—Rash—Irinotecan—breast cancer	4.81e-05	0.000621	CcSEcCtD
Nandrolone decanoate—Dermatitis—Mitoxantrone—breast cancer	4.81e-05	0.000621	CcSEcCtD
Nandrolone decanoate—Dermatitis—Irinotecan—breast cancer	4.81e-05	0.000621	CcSEcCtD
Nandrolone decanoate—Rash—Gemcitabine—breast cancer	4.69e-05	0.000605	CcSEcCtD
Nandrolone decanoate—Dermatitis—Gemcitabine—breast cancer	4.68e-05	0.000604	CcSEcCtD
Nandrolone decanoate—Progesterone—PGR—breast cancer	4.63e-05	0.0147	CrCbGaD
Nandrolone decanoate—Rash—Fluorouracil—breast cancer	4.61e-05	0.000595	CcSEcCtD
Nandrolone decanoate—Dermatitis—Fluorouracil—breast cancer	4.61e-05	0.000594	CcSEcCtD
Nandrolone decanoate—Nausea—Mitoxantrone—breast cancer	4.53e-05	0.000585	CcSEcCtD
Nandrolone decanoate—Nausea—Irinotecan—breast cancer	4.53e-05	0.000585	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Epirubicin—breast cancer	4.52e-05	0.000583	CcSEcCtD
Nandrolone decanoate—Etonogestrel—CYP3A4—breast cancer	4.46e-05	0.0142	CrCbGaD
Nandrolone decanoate—Nausea—Gemcitabine—breast cancer	4.42e-05	0.00057	CcSEcCtD
Nandrolone decanoate—Pruritus—Paclitaxel—breast cancer	4.41e-05	0.000568	CcSEcCtD
Nandrolone decanoate—Nausea—Fluorouracil—breast cancer	4.34e-05	0.00056	CcSEcCtD
Nandrolone decanoate—Progesterone—SHBG—breast cancer	4.33e-05	0.0137	CrCbGaD
Nandrolone decanoate—Progesterone—CYP1B1—breast cancer	4.33e-05	0.0137	CrCbGaD
Nandrolone decanoate—Mediastinal disorder—Doxorubicin—breast cancer	4.18e-05	0.000539	CcSEcCtD
Nandrolone decanoate—Testosterone—SHBG—breast cancer	4.09e-05	0.013	CrCbGaD
Nandrolone decanoate—Testosterone—CYP1B1—breast cancer	4.09e-05	0.013	CrCbGaD
Nandrolone decanoate—Urticaria—Capecitabine—breast cancer	4.06e-05	0.000524	CcSEcCtD
Nandrolone decanoate—Rash—Paclitaxel—breast cancer	3.93e-05	0.000507	CcSEcCtD
Nandrolone decanoate—Dermatitis—Paclitaxel—breast cancer	3.92e-05	0.000506	CcSEcCtD
Nandrolone decanoate—Progesterone—AR—breast cancer	3.79e-05	0.012	CrCbGaD
Nandrolone decanoate—Hypertension—Epirubicin—breast cancer	3.77e-05	0.000486	CcSEcCtD
Nandrolone decanoate—Pruritus—Docetaxel—breast cancer	3.73e-05	0.000482	CcSEcCtD
Nandrolone decanoate—Nausea—Paclitaxel—breast cancer	3.7e-05	0.000477	CcSEcCtD
Nandrolone decanoate—Pruritus—Capecitabine—breast cancer	3.62e-05	0.000466	CcSEcCtD
Nandrolone decanoate—Testosterone—AR—breast cancer	3.59e-05	0.0114	CrCbGaD
Nandrolone decanoate—Oedema—Epirubicin—breast cancer	3.56e-05	0.000459	CcSEcCtD
Nandrolone decanoate—Hypertension—Doxorubicin—breast cancer	3.48e-05	0.00045	CcSEcCtD
Nandrolone decanoate—Rash—Docetaxel—breast cancer	3.33e-05	0.000429	CcSEcCtD
Nandrolone decanoate—Dermatitis—Docetaxel—breast cancer	3.32e-05	0.000429	CcSEcCtD
Nandrolone decanoate—Oedema—Doxorubicin—breast cancer	3.29e-05	0.000425	CcSEcCtD
Nandrolone decanoate—Rash—Capecitabine—breast cancer	3.22e-05	0.000416	CcSEcCtD
Nandrolone decanoate—Dermatitis—Capecitabine—breast cancer	3.22e-05	0.000415	CcSEcCtD
Nandrolone decanoate—Levonorgestrel—CYP3A4—breast cancer	3.16e-05	0.01	CrCbGaD
Nandrolone decanoate—Nausea—Docetaxel—breast cancer	3.13e-05	0.000404	CcSEcCtD
Nandrolone decanoate—Nausea—Capecitabine—breast cancer	3.04e-05	0.000392	CcSEcCtD
Nandrolone decanoate—Urticaria—Methotrexate—breast cancer	3.02e-05	0.00039	CcSEcCtD
Nandrolone decanoate—Testosterone—CYP19A1—breast cancer	3e-05	0.00952	CrCbGaD
Nandrolone decanoate—Progesterone—ESR1—breast cancer	2.92e-05	0.00927	CrCbGaD
Nandrolone decanoate—Urticaria—Epirubicin—breast cancer	2.83e-05	0.000365	CcSEcCtD
Nandrolone decanoate—Testosterone—ABCG2—breast cancer	2.82e-05	0.00894	CrCbGaD
Nandrolone decanoate—Pruritus—Methotrexate—breast cancer	2.69e-05	0.000347	CcSEcCtD
Nandrolone decanoate—Urticaria—Doxorubicin—breast cancer	2.62e-05	0.000338	CcSEcCtD
Nandrolone decanoate—Norethindrone—CYP3A4—breast cancer	2.56e-05	0.00812	CrCbGaD
Nandrolone decanoate—Pruritus—Epirubicin—breast cancer	2.52e-05	0.000325	CcSEcCtD
Nandrolone decanoate—Rash—Methotrexate—breast cancer	2.4e-05	0.000309	CcSEcCtD
Nandrolone decanoate—Dermatitis—Methotrexate—breast cancer	2.4e-05	0.000309	CcSEcCtD
Nandrolone decanoate—Progesterone—CYP1A1—breast cancer	2.34e-05	0.00741	CrCbGaD
Nandrolone decanoate—Pruritus—Doxorubicin—breast cancer	2.33e-05	0.000301	CcSEcCtD
Nandrolone decanoate—Nausea—Methotrexate—breast cancer	2.26e-05	0.000292	CcSEcCtD
Nandrolone decanoate—Rash—Epirubicin—breast cancer	2.24e-05	0.00029	CcSEcCtD
Nandrolone decanoate—Dermatitis—Epirubicin—breast cancer	2.24e-05	0.000289	CcSEcCtD
Nandrolone decanoate—Norethindrone—ALB—breast cancer	2.23e-05	0.00708	CrCbGaD
Nandrolone decanoate—Testosterone—CYP1A1—breast cancer	2.21e-05	0.007	CrCbGaD
Nandrolone decanoate—Norethindrone—ABCB1—breast cancer	2.13e-05	0.00676	CrCbGaD
Nandrolone decanoate—Nausea—Epirubicin—breast cancer	2.11e-05	0.000273	CcSEcCtD
Nandrolone decanoate—Rash—Doxorubicin—breast cancer	2.08e-05	0.000268	CcSEcCtD
Nandrolone decanoate—Dermatitis—Doxorubicin—breast cancer	2.07e-05	0.000268	CcSEcCtD
Nandrolone decanoate—Nausea—Doxorubicin—breast cancer	1.96e-05	0.000252	CcSEcCtD
Nandrolone decanoate—Progesterone—CYP2D6—breast cancer	1.74e-05	0.00551	CrCbGaD
Nandrolone decanoate—Progesterone—CYP3A4—breast cancer	1.49e-05	0.00473	CrCbGaD
Nandrolone decanoate—Testosterone—CYP3A4—breast cancer	1.41e-05	0.00447	CrCbGaD
Nandrolone decanoate—AR—Gene Expression—RPS7—breast cancer	1.34e-05	0.000248	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MYC—breast cancer	1.33e-05	0.000248	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—HPGDS—breast cancer	1.33e-05	0.000248	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—HBA1—breast cancer	1.32e-05	0.000246	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—UMPS—breast cancer	1.32e-05	0.000246	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—FHL2—breast cancer	1.32e-05	0.000246	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ADSL—breast cancer	1.32e-05	0.000246	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NME1—breast cancer	1.32e-05	0.000246	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PHGDH—breast cancer	1.32e-05	0.000246	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	1.32e-05	0.000246	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—breast cancer	1.31e-05	0.000243	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—BRIP1—breast cancer	1.3e-05	0.000241	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—LDHB—breast cancer	1.3e-05	0.000241	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—HPSE—breast cancer	1.3e-05	0.000241	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTT1—breast cancer	1.29e-05	0.00024	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ACHE—breast cancer	1.29e-05	0.00024	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PHGDH—breast cancer	1.29e-05	0.00024	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—FHL2—breast cancer	1.29e-05	0.00024	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NME1—breast cancer	1.29e-05	0.00024	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ADSL—breast cancer	1.29e-05	0.00024	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—UMPS—breast cancer	1.29e-05	0.00024	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	1.28e-05	0.000239	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	1.28e-05	0.000239	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—TP53—breast cancer	1.27e-05	0.000237	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—LDHB—breast cancer	1.26e-05	0.000235	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—BRIP1—breast cancer	1.26e-05	0.000235	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—HPSE—breast cancer	1.26e-05	0.000235	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	1.26e-05	0.000234	CbGpPWpGaD
Nandrolone decanoate—Progesterone—ABCB1—breast cancer	1.24e-05	0.00394	CrCbGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—TNF—breast cancer	1.24e-05	0.000231	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—breast cancer	1.23e-05	0.000229	CbGpPWpGaD
Nandrolone decanoate—Testosterone—ALB—breast cancer	1.23e-05	0.0039	CrCbGaD
Nandrolone decanoate—MAOA—Metabolism—GSTA3—breast cancer	1.23e-05	0.000229	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—HMMR—breast cancer	1.23e-05	0.000229	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ABCC1—breast cancer	1.23e-05	0.000229	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—ESR1—breast cancer	1.23e-05	0.000228	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP17A1—breast cancer	1.22e-05	0.000227	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NOTCH4—breast cancer	1.21e-05	0.000225	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ENO1—breast cancer	1.21e-05	0.000225	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PTGS1—breast cancer	1.21e-05	0.000225	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTA3—breast cancer	1.2e-05	0.000223	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ABCC1—breast cancer	1.2e-05	0.000223	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—HMMR—breast cancer	1.2e-05	0.000223	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—MDM2—breast cancer	1.2e-05	0.000223	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	1.2e-05	0.000223	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—RAF1—breast cancer	1.19e-05	0.000222	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PPARGC1B—breast cancer	1.19e-05	0.000221	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	1.19e-05	0.000221	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP2D6—breast cancer	1.19e-05	0.000221	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—NOTCH1—breast cancer	1.19e-05	0.000221	CbGpPWpGaD
Nandrolone decanoate—Testosterone—ABCB1—breast cancer	1.17e-05	0.00372	CrCbGaD
Nandrolone decanoate—MAOB—Metabolism—NCOA2—breast cancer	1.16e-05	0.000217	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PPARGC1B—breast cancer	1.16e-05	0.000216	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—HSPA1B—breast cancer	1.15e-05	0.000215	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—IL6—breast cancer	1.14e-05	0.000211	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.13e-05	0.00021	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.13e-05	0.00021	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—FASN—breast cancer	1.13e-05	0.00021	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—BCHE—breast cancer	1.12e-05	0.000209	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTA4—breast cancer	1.12e-05	0.000209	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CA9—breast cancer	1.12e-05	0.000209	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—SLC5A5—breast cancer	1.11e-05	0.000207	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—PGR—breast cancer	1.11e-05	0.000206	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTA4—breast cancer	1.1e-05	0.000204	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CA9—breast cancer	1.1e-05	0.000204	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—TP53—breast cancer	1.1e-05	0.000204	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GPX2—breast cancer	1.1e-05	0.000204	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTA2—breast cancer	1.1e-05	0.000204	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	1.09e-05	0.000203	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—DNMT1—breast cancer	1.09e-05	0.000202	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.08e-05	0.000201	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GPX4—breast cancer	1.08e-05	0.000201	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SULT1A1—breast cancer	1.08e-05	0.000201	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—AKT1—breast cancer	1.08e-05	0.0002	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NQO1—breast cancer	1.07e-05	0.0002	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—SLC2A1—breast cancer	1.07e-05	0.0002	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.07e-05	0.000199	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTA2—breast cancer	1.07e-05	0.000199	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GPX2—breast cancer	1.07e-05	0.000199	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NCOA2—breast cancer	1.07e-05	0.000198	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—IDH1—breast cancer	1.06e-05	0.000197	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTA1—breast cancer	1.06e-05	0.000197	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	1.06e-05	0.000196	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GPX4—breast cancer	1.06e-05	0.000196	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SULT1A1—breast cancer	1.06e-05	0.000196	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—EZH2—breast cancer	1.05e-05	0.000196	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP3A4—breast cancer	1.05e-05	0.000195	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NAT2—breast cancer	1.04e-05	0.000194	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTA1—breast cancer	1.03e-05	0.000192	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—IDH1—breast cancer	1.03e-05	0.000192	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—PARP1—breast cancer	1.03e-05	0.000191	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NOTCH3—breast cancer	1.03e-05	0.000191	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP1B1—breast cancer	1.03e-05	0.000191	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NAT2—breast cancer	1.02e-05	0.00019	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—HSP90AA1—breast cancer	1.01e-05	0.000188	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—SERPINE1—breast cancer	1.01e-05	0.000188	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—RPS6—breast cancer	1e-05	0.000187	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—IL6—breast cancer	1e-05	0.000186	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NCOA1—breast cancer	9.81e-06	0.000183	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—ESR2—breast cancer	9.74e-06	0.000181	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—STK11—breast cancer	9.67e-06	0.00018	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP19A1—breast cancer	9.67e-06	0.00018	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—breast cancer	9.25e-06	0.000172	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NOTCH2—breast cancer	9.23e-06	0.000172	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—breast cancer	9.21e-06	0.000171	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—MED12—breast cancer	9.16e-06	0.00017	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—DPYD—breast cancer	9.16e-06	0.00017	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ALDOA—breast cancer	9.02e-06	0.000168	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—COMT—breast cancer	8.99e-06	0.000167	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NCOA1—breast cancer	8.98e-06	0.000167	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTP1—breast cancer	8.95e-06	0.000166	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—MED12—breast cancer	8.93e-06	0.000166	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—DPYD—breast cancer	8.93e-06	0.000166	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	8.91e-06	0.000166	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—HMOX1—breast cancer	8.82e-06	0.000164	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ITPR1—breast cancer	8.8e-06	0.000164	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ALDOA—breast cancer	8.8e-06	0.000164	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NCOA3—breast cancer	8.75e-06	0.000163	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SLC2A2—breast cancer	8.69e-06	0.000162	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—HRAS—breast cancer	8.58e-06	0.00016	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NCOA3—breast cancer	8.54e-06	0.000159	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ABCG2—breast cancer	8.52e-06	0.000158	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—MTR—breast cancer	8.52e-06	0.000158	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CPT1A—breast cancer	8.52e-06	0.000158	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SLC2A2—breast cancer	8.48e-06	0.000158	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ABCB1—breast cancer	8.47e-06	0.000158	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	8.39e-06	0.000156	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—HPGDS—breast cancer	8.35e-06	0.000155	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—TYMS—breast cancer	8.32e-06	0.000155	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ABCG2—breast cancer	8.31e-06	0.000155	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CPT1A—breast cancer	8.31e-06	0.000155	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—MTR—breast cancer	8.31e-06	0.000155	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—HBA1—breast cancer	8.3e-06	0.000154	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PLA2G4A—breast cancer	8.22e-06	0.000153	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTM1—breast cancer	8.22e-06	0.000153	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NCOR1—breast cancer	8.22e-06	0.000153	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—HPGDS—breast cancer	8.15e-06	0.000152	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ACHE—breast cancer	8.1e-06	0.000151	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTT1—breast cancer	8.1e-06	0.000151	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—HBA1—breast cancer	8.09e-06	0.000151	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ACHE—breast cancer	7.9e-06	0.000147	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTT1—breast cancer	7.9e-06	0.000147	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GPX1—breast cancer	7.87e-06	0.000147	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—SIRT1—breast cancer	7.85e-06	0.000146	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP1A1—breast cancer	7.79e-06	0.000145	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—SMAD4—breast cancer	7.75e-06	0.000144	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—VDR—breast cancer	7.73e-06	0.000144	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ERCC2—breast cancer	7.73e-06	0.000144	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP17A1—breast cancer	7.67e-06	0.000143	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PTGS1—breast cancer	7.59e-06	0.000141	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ENO1—breast cancer	7.59e-06	0.000141	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NCOR1—breast cancer	7.52e-06	0.00014	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP17A1—breast cancer	7.48e-06	0.000139	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP2D6—breast cancer	7.44e-06	0.000139	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PTGS1—breast cancer	7.4e-06	0.000138	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ENO1—breast cancer	7.4e-06	0.000138	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	7.38e-06	0.000137	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—H2AFX—breast cancer	7.33e-06	0.000136	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NCOA2—breast cancer	7.31e-06	0.000136	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—breast cancer	7.28e-06	0.000135	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—MTHFR—breast cancer	7.27e-06	0.000135	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP2D6—breast cancer	7.26e-06	0.000135	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NCOA2—breast cancer	7.13e-06	0.000133	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—FASN—breast cancer	7.09e-06	0.000132	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—ERCC2—breast cancer	7.07e-06	0.000132	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—BCHE—breast cancer	7.06e-06	0.000131	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SLC5A5—breast cancer	6.97e-06	0.00013	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—FASN—breast cancer	6.91e-06	0.000129	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—BCHE—breast cancer	6.88e-06	0.000128	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SLC5A5—breast cancer	6.8e-06	0.000126	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SLC2A1—breast cancer	6.73e-06	0.000125	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NQO1—breast cancer	6.73e-06	0.000125	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CAV1—breast cancer	6.7e-06	0.000125	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—HRAS—breast cancer	6.57e-06	0.000122	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NQO1—breast cancer	6.57e-06	0.000122	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SLC2A1—breast cancer	6.57e-06	0.000122	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP3A4—breast cancer	6.56e-06	0.000122	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP1B1—breast cancer	6.45e-06	0.00012	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	6.43e-06	0.00012	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP3A4—breast cancer	6.4e-06	0.000119	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—MYC—breast cancer	6.38e-06	0.000119	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	6.37e-06	0.000119	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—HSP90AA1—breast cancer	6.33e-06	0.000118	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP1B1—breast cancer	6.29e-06	0.000117	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—HSP90AA1—breast cancer	6.17e-06	0.000115	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NCOA1—breast cancer	6.16e-06	0.000115	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CG—breast cancer	6.11e-06	0.000114	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—STK11—breast cancer	6.07e-06	0.000113	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP19A1—breast cancer	6.07e-06	0.000113	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NCOA1—breast cancer	6.01e-06	0.000112	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—STK11—breast cancer	5.92e-06	0.00011	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—ESR1—breast cancer	5.91e-06	0.00011	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NOTCH1—breast cancer	5.71e-06	0.000106	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—COMT—breast cancer	5.64e-06	0.000105	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTP1—breast cancer	5.61e-06	0.000104	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.56e-06	0.000103	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—HMOX1—breast cancer	5.54e-06	0.000103	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ITPR1—breast cancer	5.52e-06	0.000103	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—COMT—breast cancer	5.5e-06	0.000102	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTP1—breast cancer	5.48e-06	0.000102	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—HMOX1—breast cancer	5.4e-06	0.0001	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ITPR1—breast cancer	5.39e-06	0.0001	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CD—breast cancer	5.37e-06	9.99e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ABCB1—breast cancer	5.31e-06	9.89e-05	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ALB—breast cancer	5.3e-06	9.86e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—TYMS—breast cancer	5.22e-06	9.71e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ABCB1—breast cancer	5.18e-06	9.65e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PLA2G4A—breast cancer	5.16e-06	9.6e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NCOR1—breast cancer	5.16e-06	9.6e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTM1—breast cancer	5.16e-06	9.6e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—TYMS—breast cancer	5.09e-06	9.47e-05	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NOS3—breast cancer	5.07e-06	9.43e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NCOR1—breast cancer	5.03e-06	9.36e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PLA2G4A—breast cancer	5.03e-06	9.36e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTM1—breast cancer	5.03e-06	9.36e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GPX1—breast cancer	4.94e-06	9.19e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP1A1—breast cancer	4.89e-06	9.1e-05	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—SERPINE1—breast cancer	4.86e-06	9.04e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ERCC2—breast cancer	4.85e-06	9.03e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GPX1—breast cancer	4.82e-06	8.97e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP1A1—breast cancer	4.77e-06	8.88e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ERCC2—breast cancer	4.73e-06	8.8e-05	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CB—breast cancer	4.68e-06	8.71e-05	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PTGS2—breast cancer	4.64e-06	8.63e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—MTHFR—breast cancer	4.56e-06	8.48e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—MTHFR—breast cancer	4.45e-06	8.28e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CAV1—breast cancer	4.21e-06	7.83e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CAV1—breast cancer	4.1e-06	7.63e-05	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PTEN—breast cancer	4.04e-06	7.52e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.92e-06	7.29e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CG—breast cancer	3.83e-06	7.13e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CG—breast cancer	3.74e-06	6.95e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CD—breast cancer	3.37e-06	6.27e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ALB—breast cancer	3.32e-06	6.19e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CD—breast cancer	3.28e-06	6.11e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ALB—breast cancer	3.24e-06	6.03e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NOS3—breast cancer	3.18e-06	5.92e-05	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—MAPK3—breast cancer	3.16e-06	5.88e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NOS3—breast cancer	3.1e-06	5.77e-05	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—MYC—breast cancer	3.07e-06	5.72e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CB—breast cancer	2.94e-06	5.46e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PTGS2—breast cancer	2.91e-06	5.41e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CB—breast cancer	2.86e-06	5.33e-05	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CA—breast cancer	2.85e-06	5.31e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PTGS2—breast cancer	2.84e-06	5.28e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PTEN—breast cancer	2.54e-06	4.72e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PTEN—breast cancer	2.47e-06	4.6e-05	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—AKT1—breast cancer	2.33e-06	4.34e-05	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—AKT1—breast cancer	2.13e-06	3.97e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CA—breast cancer	1.79e-06	3.33e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CA—breast cancer	1.75e-06	3.25e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—AKT1—breast cancer	1.46e-06	2.72e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—AKT1—breast cancer	1.43e-06	2.65e-05	CbGpPWpGaD
